Recent News for SRPT - Sarepta Therapeutics, Inc.

Date Title
Sep 6 SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses in Excess of $50,000 to Contact the Firm
Sep 5 SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SRPT
Sep 5 SHAREHOLDER ALERT: EGBN NTAP SRPT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
Sep 5 IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Sep 5 Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program
Sep 5 The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of JE, EVH and SRPT
Sep 5 Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Sarepta Therapeutics, Inc. (SRPT)
Sep 5 The Gross Law Firm Announces Class Actions on Behalf of Shareholders of JE, CURLF and SRPT
Sep 5 INVESTOR ALERT - Sarepta Therapeutics, Inc. (SRPT) - Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Class Action and Lead Deadline: October 29, 2019
Sep 4 The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of RLGY, OMCL and SRPT
Sep 4 CLASS ACTION UPDATE for JE, TWOU, EVH and SRPT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Sep 4 LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Sarepta Therapeutics, Inc. To Contact The Firm
Sep 3 Sarepta Therapeutics to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
Sep 3 SHAREHOLDER ALERT - Sarepta Therapeutics, Inc. (SRPT) - Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Class Action and Lead Deadline: October 29, 2019
Sep 2 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - SRPT
Aug 31 INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Sarepta Therapeutics, Inc.
Aug 30 After The Dust Has Settled, Key Sarepta Therapeutics Insiders Are Still Buying Shares And So Should Investors
Aug 30 Pomerantz Law Firm Announces the Filing of a Class Action against Sarepta Therapeutics, Inc. and Certain Officers - SRPT
Aug 29 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT
Aug 29 Citi: Solid Biosciences Rally Unsupported By Fundamentals
Aug 28 Sarepta: A Controversial CRL Provides Buying Opportunity
Aug 26 Sarepta: Not This Time!
Aug 26 We See Opportunity In Sarepta
Aug 25 The Week Ahead In Biotech: A Quiet One Ahead Of Labor Day Weekend
Aug 25 Is Sarepta Therapeutics a Bad News Buy?
Back to the Main SRPT Page...